Allianz Asset Management GmbH Sells 5,415 Shares of Axcelis Technologies, Inc. $ACLS

Allianz Asset Management GmbH decreased its position in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 42.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 7,315 shares of the semiconductor company’s stock after selling 5,415 shares during the period. Allianz Asset Management GmbH’s holdings in Axcelis Technologies were worth $714,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ACLS. American Century Companies Inc. increased its holdings in Axcelis Technologies by 45.5% during the 2nd quarter. American Century Companies Inc. now owns 1,659,463 shares of the semiconductor company’s stock valued at $115,648,000 after purchasing an additional 518,968 shares during the period. Boston Partners increased its position in Axcelis Technologies by 42.3% during the 2nd quarter. Boston Partners now owns 474,043 shares of the semiconductor company’s stock valued at $33,616,000 after purchasing an additional 141,004 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Axcelis Technologies by 1,344.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 109,628 shares of the semiconductor company’s stock worth $10,388,000 after purchasing an additional 102,040 shares in the last quarter. Reinhart Partners LLC. lifted its position in shares of Axcelis Technologies by 6.0% in the 3rd quarter. Reinhart Partners LLC. now owns 1,610,332 shares of the semiconductor company’s stock worth $157,234,000 after purchasing an additional 91,788 shares during the period. Finally, Balyasny Asset Management L.P. bought a new stake in shares of Axcelis Technologies during the 2nd quarter valued at about $6,324,000. 89.98% of the stock is currently owned by institutional investors.

Insider Transactions at Axcelis Technologies

In other Axcelis Technologies news, EVP Gerald M. Blumenstock sold 3,034 shares of Axcelis Technologies stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $89.46, for a total value of $271,421.64. Following the completion of the transaction, the executive vice president directly owned 18,661 shares of the company’s stock, valued at approximately $1,669,413.06. The trade was a 13.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jorge Titinger sold 2,000 shares of the stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $86.05, for a total transaction of $172,100.00. Following the sale, the director owned 7,477 shares in the company, valued at approximately $643,395.85. The trade was a 21.10% decrease in their position. The SEC filing for this sale provides additional information. 0.48% of the stock is currently owned by company insiders.

Axcelis Technologies Trading Up 4.4%

NASDAQ ACLS opened at $94.55 on Friday. Axcelis Technologies, Inc. has a 12 month low of $40.40 and a 12 month high of $102.93. The company has a current ratio of 4.95, a quick ratio of 3.32 and a debt-to-equity ratio of 0.04. The stock’s fifty day moving average price is $88.23 and its 200-day moving average price is $85.18. The stock has a market cap of $2.90 billion, a P/E ratio of 22.35 and a beta of 1.77.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ACLS. Weiss Ratings reissued a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Monday, December 22nd. B. Riley Financial upped their target price on Axcelis Technologies from $84.00 to $94.00 and gave the stock a “neutral” rating in a report on Wednesday, January 21st. Zacks Research cut Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a research note on Friday, December 5th. Bank of America lifted their price target on Axcelis Technologies from $90.00 to $100.00 and gave the company an “underperform” rating in a research report on Tuesday, January 13th. Finally, Wall Street Zen downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Axcelis Technologies currently has an average rating of “Hold” and a consensus price target of $102.25.

About Axcelis Technologies

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.